DGAP-News

Novavax to Present at the Wedbush Securities Life Sciences Management Access Conference

DGAP-News: Novavax, Inc.
Novavax to Present at the Wedbush Securities Life Sciences Management
Access Conference

07.08.2014 / 22:03

---------------------------------------------------------------------

GAITHERSBURG, Md., 2014-08-07 22:03 CEST (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biopharmaceutical company focused
on the discovery, development and commercialization of recombinant nanoparticle
vaccines and adjuvants, announced today that Barclay 'Buck' Phillips, SVP,
Chief Financial Officer and Treasurer, will present at the Wedbush Securities
Life Sciences Management Access Conference to be held on Wednesday, August 13,
2014 at 3:40 pm ET in New York City at the Le Parker Meridien hotel.

A live webcast link for the presentation will be available via the company's
website at www.novavax.com under Investor Info/Events.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating vaccines and vaccine adjuvants to address a broad range of infectious
diseases worldwide. Using innovative proprietary recombinant nanoparticle
vaccine technology, the company produces vaccine candidates to efficiently and
effectively respond to both known and newly emergent diseases.


Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Novavax, Inc.
240-268-2000
News Source: NASDAQ OMX



---------------------------------------------------------------------

07.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language: English
Company: Novavax, Inc.


United States
ISIN: US6700021040


End of News DGAP News-Service
---------------------------------------------------------------------
281402 07.08.2014